Jonathan Chen is currently VP, International Business & Investor Relations for MicroPort Scientific Corporation and has been with the company since July 2012. Mr. Chen’s primary responsibilities include growing MicroPort’s International business in markets outside of China primarily in US, Europe and South America geographies. Prior to joining MicroPort, Mr. Chen worked for Angiotech Pharmaceuticals, Inc. for 6 years where he was SVP, Business Development where he lead the management team to build a $300 million in revenue medical products business through various acquisitions and licensing transactions. Prior to joining Angiotech, Mr. Chen was a life sciences investment banker for Credit Suisse (6 years) and Alex. Brown & Sons (3 years) where he helped his clients raise in excess of $2 billion in equity and debt capital and advised on over $3 billion in Mergers & Acquisitions transactions. Mr. Chen has a Bachelor of Arts in Economics and a Bachelor of Sciences with honors in Biological Sciences from Stanford University.